Progress has been made in understanding the molecular mechanisms that regulate cell type-specific gene expression during the terminal differentiation of cells into specialized tissue types. These studies have concentrated largely on defining the cis elements and trans-acting factors responsible for the transcription of differentiation-specific genes. Valuable as these investigations have been, they have not been able to place differentiation into the larger context of development, specifically into the context ofthe earlier developmental process of cell deternination, when embryonic stem cell lineages are forned and the genetic regulatory programs for cell type-specific gene activation and expression are acquired by stem cells.
by 5-azacytidine into three mesodermal stem cell lineages. These detennined proliferative stem cells are stable in culture and retain their ability to differentiate in mitogen-depleted medium. The most significant discovery has been that 1OT1/2 lineage deternination is under simple genetic control and that the regulatory genes that mediate the formation of myogenic cell lineages, and likely the chondrogenic and adipogenic lineages, can be demonstrated and studied by genomic DNA and cDNA transfection approaches. This paper is a description of the remarkable properties and genetic behaviors of the 1OT1/2 cells and a discussion of the insights that future studies of this cell may provide.
Mesodermal Differentiation and Oncogenic Transformation
1OT1/2 cells are a clonal cell line established and characterized by Reznikoff et al. (1) . They were derived from 14-to 17 -day C3H whole mouse embryos, so their tissue of origin is unknown. The cell line was established using the method of Aaronsen and Ibdaro (2) , which selects for cells that are sensitive to postconfluence inhibition of cell division. These cells maintain a stable morphology even after long periods in culture. When subconfluent, they appear fibroblastlike with extended cytoplasmic processes. In confluent cultures, the cells form a flat, regular, epithelioidlike sheet. The modal chromosome number is stable at 81, which is hypertetraploid for mice. Expression of Ctype retroviruses could not be detected over large pas-sage numbers, and the cells were not tumorigenic when injected into irradiated and nonirradiated C3H mice. The presence and consistency of these characteristics make this cell line ideally suited for studies of malignant transformation in vitro by a variety of chemical and viral agents.
During one such study of malignant transformation by the S-triazine nucleoside analogue of cytidine, 5-azacytidine (5-Aza-CR), which is used as a cancer chemotherapeutic agent, Constantinides et al. (3) observed elongated, multinucleated cells that morphologically resembled myofibers. Further investigation showed that the multinucleated cells expressed biochemical properties of muscle so that they could contract when treated with acetylcholine (3) , had receptors to acetylcholine capable of binding a-bungarotoxin, and a calciumdependent (myosin) ATPase (4) . Consistent with these results, other researchers demonstrated the presence of an array of muscle-specific contractile proteins synthesized by 5-Aza-CR-derived myofibers (5, 6) . Thus, 1OT1/2 cells can differentiate and form muscle after treatment with 5-Aza-CR.
A later report by Taylor and Jones (7) showed that two other mesodermal phenotypes, adipocytes and chondrocytes, were expressed by 1OT1/2 cells after treatment with 5-Aza-CR at an optimal concentration identical to that which resulted in the formation of myofibers. There was a temporal order of appearance of the three differentiated phenotypes; myofibers appeared 5 to 6 days after the treated cells had reached confluence, followed by adipocytes about 4 days later, and finally chondrocytes in 9 to 16 days more. In the case of myofibers and chondrocytes, the relative order of appearance is consistent with that observed in developing chicken limb buds (8) , suggesting that the developmental timing of differentiation is preserved in this cell line following 5-Aza-CR treatment.
Adipocytes have a morphology typical of multilocular fat cells and can be stained with oil Red-O (7). To confirm the identity of this phenotype, Taylor and Jones (7) measured the accumulation of triglycerides and the activities of two key enzymes of fatty acid synthesis, ATP-citrate lyase and acetyl-CoA carboxylase. Consistent with their evidence, Chapman et al. (9) later showed that an additional enzyme activity typical of mature adipocytes, glycerophosphate dehydrogenase, increased 100-fold and that lipoprotein lipase could be detected immunologically in adipocytes derived from 1OT1/2 cells by 5-Aza-CR treatment.
The cartilage cells observed were seen in tightly packed foci of polygonal cells (7) . These cells showed metachromatic staining with toluidine blue and incorporation of "S-sulfate, both of which were reduced with digestion using chondroitinase ABC. These results suggested that the cells synthesized sulfated proteoglycans that are associated with the extracellular matrix of cartilage. In addition, these foci of cells bound antibody against type II collagen (7) .
In addition to the mesodermal phenotypes observed, Benedict et al. (10) (11, 12) . Two of these lines were subeloned (7) and treated with 5-Aza-CR and scored for myofiber for- (5) undertook a clonal analysis of 5-Aza-CR treated 1OT1/2 cells to determine whether the cells were bypassing determination or were in fact proceeding through the entire developmental program. 1OT1/2 clonal cultures were treated with 5-Aza-CR, and multiple colonies containing cells of each differentiated phenotype were recloned and expanded.
Proliferative cells from the adipogenic lines morphologically resembled 1OT1/2 cells, whereas cells from the myogenic clones were bipolar, small, and highly refractile, and cells from the chondrogenic clones appeared polygonal. The clonal populations were allowed to reach confluence and examined for differentiated cells. In every case, the clonal cell lines isolated differentiated into only the single selected cell type. Two-dimensional protein gel analyses showed that specific proteins present in 10T1/2 cell extracts were missing from the myogenic, adipogenic, and chondrogenic cell lines examined. In addition, at least one major protein appeared to be unique to the myogenic cell lines. Most significantly, muscle-specific contractile proteins could not be detected in extracts from proliferative cultures of the myogenic cell lines, whereas fusing cultures exhibited the full spectrum of differentiation-specific proteins. These results showed that, following 5-Aza-CR treatment, cells of each phenotype arose that synthesized sets of proteins that were different than those expressed by 1OT1/2 cells, the other mesodermal phenotypes, and the end point-differentiated cells. These cells were proliferative, stable, and capable of differentiation under appropriate culture conditions of low mitogen stimulation. Thus, these studies showed that 5-Aza-CR did not directly activate differentiation-specific genes but rather converted the cells into determined stem cell lineages capable of differentiating in the appropriate environment.
Consistent (14) . Neither the quail ThI gene nor the endogenous mouse skeletal a-actin gene was expressed in parental 1OT1/2 cells, a myoblast line derived from the transfected 1OT1/2 cells by 5-Aza-CR treatment, or the proliferative myogenic cell line. In contrast, these genes were expressed in fusing cultures of the myogenically converted, transfected 1OT1/2 cells and the myogenic cell line. Similar results were obtained when 1OT1/2 cells and a 5-Aza-CR-derived myogenic cell line were stably transfected with a chicken cardiac a-actin gene (6) . These results proved that 5-Aza-CR is not directly affecting contractile protein genes; the exogenously added genes were not expressed in proliferative cells even when they were introduced prior to 5-Aza-CR, but the genes were expressed by fusing cells even when they were introduced long after the cell lines had been establisbed by 5-Aza-CR treatment. The transfected genes were activated appropriately, both temporally and quantitatively, in fusing myofibers, suggesting that they are responsive to the regulatory mechanisms operating in cells converted by treatment with 5-Aza-CR. Therefore, these experiments suggest that 5-Aza-CR is involved in establishing the regulatory program that controls the expression of the differentiation-specific genes.
It is evident from the work reported that 5-Aza-CR treatment of 1OT1/2 cells can result in the establishment of distinct cell lines that fulfill the criteria of being stably determined, proliferative stem cell lines capable of differentiating and expressing their specific phenotypic genes. Further, the evidence indicates that 5-Aza-CR is not activating the differentiation-specific genes themselves but rather is inducing a determined state that activates a regulatory program capable of responding appropriately to environmental signals. In short, it appears that 5-Aza-CR is causing cell determination of certain lineages within 10T1/2 cells so that they at some point must represent multipotential, mesodermal precursor cells. It is not possible at this point to determine whether 10T1/2 cells are actually multipotential or whether 5-Aza-CR induces an unstable multipotential state. (15) showed by direct measurements of DNA methylation that 5-Aza-CR at micromolar concentrations is an efficient inhibitor of methylation in 10T1/2 cells. Decreases in methylation could be correlated with increasing 5-Aza-CR doses and with increasing myofiber formation. In these experiments the optimal concentration of 5-Aza-CR for myofiber formation was 2 ,uM, which caused a 62% decrease in cytosine methylation. Additional direct measurements showed that newly synthesized strands were significantly undermethylated when the cells were exposed to 5-Aza-CR for 20 hr and were not remethylated during a subsequent 20-hr period in the absence of 5-Aza-CR.
Consistent with the hypothesis that 5-Aza-CR acts by causing hypomethylation of DNA, the deoxy analogue, 5-aza-2'-deoxycytidine, causes myofiber formation at the same frequency but with 1/10 the concentration. Other analogues of cytidine substituted at the same position were shown to be effective inhibitors of DNA methylation and also to cause myofiber formation. Although the level of incorporation of 5-Aza-CR reached only 5% when there was an 80 to 85% inhibition of methylation, it was hypothesized that the methylating enzymes walk along the DNA so that 5-Aza-CR may impede enzyme movement and therefore inhibit methylation of additional sites.
Maximal induction of myofibers and adipocytes was shown to occur when 1OT1/2 cells were treated with 5-Aza-CR during early S phase (4, 13) . Incorporation of the analogue into DNA was not enhanced during this period of the cell cycle and there were no significant differences in incorporation into RNA throughout the cell cycle. Therefore, it was theorized that incorporation of 5-Aza-CR into specific DNA sequences synthesized during early Sphase is responsible for the conversion events. Studies of methylation patterns by Bird (16) showed that both cytosines in a CpG paired sequence are either both methylated or both unmethylated, which is consistent with theories that methylation patterns are conser-vatively replicated (17, 18) . A model proposed by Jones and Thylor (13) suggests that 5-Aza-CR would perturb the methylation patterns in 1OT1/2 DNA and that these new patterns of methylation would become set within the genome during two DNA replication cycles. This model would predict the subsequent reports that clonal cultures of 5-Aza-CR treated 1OT1/2 cells contain mixed colonies of converted and parental cells (5) or more than one converted phenotype (5,13) and would predict the subsequent segregation and stability of phenotypes (5) following recloning. Although there has been no direct demonstration that hypomethylation of specific DNA loci by 5-Aza-CR results in conversion of 1OT1/2 cells, these results strongly support this mechanism of action.
The high frequency of conversion makes the 1OT1/2 cell line a particularly attractive model system in which to study determination. In addition, these frequencies suggest a model that proposes a simple genetic basis for determination. Taylor and Jones (13) (19) isolated genomic DNA from a 1OT1/2-derived myoblast cell line and from embryonic quail myoblasts. Each genomic DNA was cotransfected with a plasmid containing a gene conferring resistance to the antibiotic G418. In each case, the frequency of myogenic conversion was 2 x 10 -4 G418-resistant cells. In addition, Lassar et al. (6) demonstrated in a similar transfection experiment that transfection of 1OT1/2 with genomic DNAs isolated from a 1OT1/2-derived myoblast cell line or from the mouse C2C12 myoblast cell line resulted in myogenic conversion frequencies of about 7 x 10 -5 G418-resistant cells. These experiments, although suggestive, are limited in their interpretations. Since no marker was associated with the transfected genomic DNA, there was no method to confirm that the exogenously added DNAs were responsible for the observed conversion events. In fact, Lassar et al. reported a high frequency of spontaneous conversion (6) .
A more direct test of the model has been performed by Pinney et al. (20) . 
Proposed Models of Myogenic Determination
The studies reviewed in this article provide compelling evidence that conversion of 1OT1/2 cells into determined stem cell lineages has a simple genetic basis. In the case of myogenic conversion, determination appears to be controlled by activation of a single determination locus, which for the sake of discussion will be called myd, probably by a hypomethylation mechanism. The activation of this myogenic determination gene causes profound changes in gene expression, suggesting that the myd locus is responsible for establishing a new regulatory program that must include repression of the synthesis of a specific set of 1OT1/2 cell proteins, activation of the synthesis of myoblast-specific proteins, and preparation of a transcriptional regulatory program for the differentiation-specific activation of muscle protein genes.
We can imagine three general mechanisms by which a myogenic determination gene might establish the regulatory changes involved in the myoblast determination process. The first is a master regulatory gene mechanism in which the product of myd gene acts directly upon all three classes of determination-specific genes, i.e., to repress 1OT1/2 cell-specific genes, to induce myoblast genes, and to prepare a transcriptional control system for the activation of muscle genes (Fig. lA) . The second is a parallel regulatory gene pathway mechanism in which myd initiates, and perhaps maintains, a secondary set of regulatory genes that would, in turn, control the myoblast-specific processes (Fig. 1B) . A third possibility is a hierarchical pathway model in which myd would induce secondary regulatory genes, which would subsequently activate a tertiary set of muscle-specific regulatory genes (Fig. 1C) Significant progress has been made in understanding the molecular mechanisms involved in cell lineage determination and differentiation using the 1OT1/2 cell line. The remarkable properties of 1OT1/2 cells suggested models of detennination and the advantages of a clonal tissue culture system have allowed researchers to test these hypotheses using DNA transfection approaches. Perhaps the most outstanding conclusion reached is that a developmental decision, myogenic determination, is under simple genetic control and may primarily involve the establishment of transcriptional regulatory programs. It is reasonable to expect that similar mechanisms will be discovered that regulate the establishment of adipogenic and chondrogenic lineages in the 1OT1/2 cell and that the approaches used to investigate myogenic determination can be applied. Furthermore, the experimental approaches and findings developed in studies of 1OT1/2 cells offer a new paradigm for both in vitro and in vivo investigations of embryonic determination in a variety of different embryonic lineages.
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